Stockscreener 앱 받기
16.58
0.09%
0.0033
전일 마감가:
$16.58
열려 있는:
$16.69
하루 거래량:
10,619
Relative Volume:
0.02
시가총액:
$573.57M
수익:
$90.44M
순이익/손실:
$561.00K
주가수익비율:
2,762.78
EPS:
0.006
순현금흐름:
$19.19M
1주 성능:
+1.25%
1개월 성능:
+27.26%
6개월 성능:
+92.97%
1년 성능:
+52.25%
1일 변동 폭
$16.53
$16.69
1주일 범위
$16.10
$16.78
52주 변동 폭
$8.12
$17.42
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
16.53 | 581.20M | 90.44M | 561.00K | 19.19M | 0.006 |
ABT
Abbott Laboratories
|
110.83 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
316.11 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.97 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
48.37 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.87 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath (DCTH) Earnings Reading: EPS Comes in Above Forecast at the Close; Stock Move: Shares Move Lower 1.52% in Latest TradingPost-Earnings Drift - vinanet.vn
Delcath Systems Inc (DCTH) (Q2 2026) Earnings Call Highlights: R - GuruFocus
Delcath Systems Q2 2026 Earnings: EPS Surges to $0.07, Defying Loss EstimatesTrough Earnings Signal - vinanet.vn
These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months - Stocktwits
DCTH Q2 2026 Earnings: EPS Flips to $0.07 vs. Expected Loss — A 176% Surprise Despite Share Pullback - vinanet.vn
Liquidity Mapping Around (DCTH) Price Events - Stock Traders Daily
Delcath Adopts Exclusive Forum Provisions in Amended Bylaws - Minichart
Delcath Systems updates bylaws to designate Delaware courts as exclusive forum - Investing.com
Form 8K Delcath Systems Inc For: 14 August By Investing.com - Investing.com Australia
Delcath Systems (DCTH) adopts new exclusive forum clauses in amended bylaws - Stock Titan
DCTH Q2 2026 Earnings: Surprise EPS of $0.07 Beats Estimates by 176.25%Revenue Surprise History - vinanet.vn
Renaissance Technologies LLC Trims Position in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Zacks Research - MarketBeat
Delcath Systems (NASDAQ:DCTH) Hits New 12-Month HighHere's What Happened - MarketBeat
Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy - Yahoo Finance
Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect? - Yahoo Finance
HC Wainwright Boosts Earnings Estimates for Delcath Systems - MarketBeat
Delcath Systems resumes post-earnings momentum with 10% rally, sets new high (DCTH:NASDAQ) - Seeking Alpha
Delcath Systems (NASDAQ:DCTH) Trading 9.3% HigherStill a Buy? - MarketBeat
Why Are Delcath Systems, Inc. (NASDAQ:DCTH) Shares at a Fresh Yearly High? - Kalkine Media
Delcath Systems Inc. (US24661P8077.SG) analyst ratings, estimates and forecasts - Yahoo Finance UK
HC Wainwright Weighs in on Delcath Systems Q1 Earnings - MarketBeat
Biotech company expanding Washington County HQ - The Business Journals
Delcath Systems Insider Confidence Rewarded, Stock Hits US$536m Market Cap - 富途牛牛
Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Delcath Systems (NASDAQ:DCTH) Issues Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat
DCTH Maintained by HC Wainwright & Co. -- Price Target Raised to $32 - GuruFocus
Delcath: Temporary Headwinds Are Fading While Larger Opportunities Approach (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems Inc (DCTH) Stock News Today - TradingKey
H.C. Wainwright Maintains Delcath Systems(DCTH.US) With Buy Rating, Raises Target Price to $32 - Moomoo
Craig-Hallum Maintains Delcath Systems(DCTH.US) With Buy Rating, Announces Target Price $24 - Moomoo
Delcath Systems, Inc. (DCTH) Stock Analysis: A Promising 52.24% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Delcath Systems Q2 Revenue Rises to $29.1 Million - Moomoo
Delcath Systems earnings beat by $0.17, revenue topped estimates - Investing.com Canada
Earnings call transcript: Delcath jumps on Q2 2026 revenue beat and raised outlook - Investing.com South Africa
Delcath Systems, Inc. Stock 12‑Month Price Target Raised to $24.17, Implies 91% Upside - TradingView
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $21.00 at BTIG Research - MarketBeat
Delcath Systems Inc (DCTH) Beats Revenue Estimates with $29.1 Mi - GuruFocus
Delcath Systems Announces Q2 2026 Financial Results Highlighting Revenue Growth - Kalkine Media
Delcath Systems Up Over 20%, On Pace for Largest Percent Increase Since May 2025 -- Data Talk - Moomoo
Delcath Systems Q2 Earnings Call Highlights - marketbeat.com
Delcath Systems (NASDAQ:DCTH) Sets New 12-Month High After Better-Than-Expected Earnings - MarketBeat
Delcath Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Delcath Systems Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DCTH: Q2 revenue up 21% year-over-year, with raised full-year guidance and expanding clinical reach - TradingView
Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Transcript : Delcath Systems, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
DCTH: Q2 2026 revenue grew 21% to $29.1M, with strong HEPZATO sales and steady profitability - TradingView
DELCATH SYSTEMS, INC. 1Q 2026: Revenue $29.13M, EPS $0.07— 10-Q Summary - TradingView
Delcath Systems (NASDAQ: DCTH) posts Q2 profit and builds oncology pipeline - Stock Titan
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Delcath Systems Inc 주식 (DCTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sylvester John Richard | Director |
Nov 21 '25 |
Buy |
8.89 |
4,386 |
38,992 |
14,936 |
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
1.99%
0.49%
자본화:
|
볼륨(24시간):